In addition, recent in vivo experiments in mice revealed that eukaryotic elongation factor 2 kinase (eEF2K) (57) promotes immunosuppression of melanoma via PD-L1 stabilization mediated by GSK3β inactivation. This evidence concerns the gene EEF2K and melanoma.